EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer

Yilei Yang, Luyao Liu, Haochen Cui, Bin Cheng, Wang Peng, Ronghua Wang, Jinlin Wang, Wei Chen, Mengdie Cao, Yanling Li, Jingwen Liang, Shiru Chen und 2 weitere

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgae072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Yilei Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang A…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Biomarkers, Tumor, Diabetes Mellitus, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New-onset diabetes (NOD) is a common condition among patients with pancreatic adenocarcinoma (PAAD) and is related to poor clinical outcomes. The potential impact of NOD on PAAD progression and the tumor microenvironment remains unclear. Here, we revealed that NOD in PAAD was associated with metabolic disorders. Utilizing three machine-learning algorithms, an NOD-related metabolism signature (NRMS) was established. Validated in three independent cohorts, patients with a high NRMS score exhibited a worse prognosis. Moreover, an elevated NRMS score was associated with an immunosuppressive microenvironment and diminished response to immunotherapy. Further experiments demonstrated that ALDH3A1, a key feature in NRMS, was significantly upregulated in tissues from PAAD patients with NOD and played a crucial role in tumor progression and immune suppression. Our findings highlight the potential of NRMS as a prognostic biomarker and an indicator of immunotherapy response for patients with PAAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsBiomarkers, TumorDiabetes MellitusAdenocarcinomaHumansPrognosisTumor MicroenvironmentMaleFemaleMiddle AgedImmunotherapyGene Expression Regulation, NeoplasticMachine LearningDisease Progression

Stichwörter der Autor:innen

metabolismnew-onset diabetespancreatic adenocarcinomatumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China.
  • Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.
  • Department of Surgery, University of Pittsburgh School of Medicine, 3550 Terrace Street, Pittsburg, PA 15213M, United States.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, China.

ORCID-Profile: Yuchong Zhao

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, Y., Liu, L., Cui, H., Cheng, B., Peng, W., Wang, R., Wang, J., Chen, W., Cao, M., Li, Y., Liang, J., Chen, S., Bai, S., & Zhao, Y. (2025). Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgae072

Vancouver

Yang Y, Liu L, Cui H, Cheng B, Peng W, Wang R, et al. Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer. Carcinogenesis. 2025. doi:10.1093/carcin/bgae072

BibTeX
@article{Yang2025,
  author = {Yang, Yilei and Liu, Luyao and Cui, Haochen and Cheng, Bin and Peng, Wang and Wang, Ronghua and Wang, Jinlin and Chen, Wei and Cao, Mengdie and Li, Yanling and Liang, Jingwen and Chen, Shiru and Bai, Shuya and Zhao, Yuchong},
  title = {Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgae072}
}
Kostenlos starten →